My Brother Died Suddenly at 32. What Happens Now?

If your brother died suddenly and no one can tell you why, the fear that quietly arrives a few days later is a reasonable one: if it was his heart, and nothing warned him, could the same thing be waiting in the rest of you. It is the right question to ask, and there is an established answer. After a sudden, unexplained death in a young adult, the surviving first-degree relatives — parents, brothers, sisters and any children — are usually offered heart screening through a specialist NHS service.

That offer exists precisely because some of the conditions that cause a sudden cardiac death in a young person can run in families and can sit silently, without a single symptom, until they don't. The point of screening is not to frighten you further. It is that most of these conditions, once found, can be watched and managed, and some are very treatable. Finding out is the useful thing.

This page walks the pathway you are likely to be offered, explains what the doctors are actually looking for, and answers the question that surprises people who are grieving and also, at some point, filling in a life insurance form: how does any of this sit on an application.

What "sudden adult death syndrome" actually means

When a young person dies suddenly of a cardiac cause and a post-mortem finds a structurally normal heart with no clear reason, the death is sometimes labelled sudden adult death syndrome, or sudden arrhythmic death syndrome. The label is not really a diagnosis. It is an admission that the heart looked normal on examination but stopped anyway, which points towards a problem in the heart's electrical wiring rather than its structure — the kind of fault that leaves no mark a pathologist can see.

That is the part families find hardest. A normal-looking heart feels like it should be reassuring, and instead it produces the most unsettling verdict of all: no cause found. It does not mean nothing was wrong. It means the thing that was wrong is the sort that does not show up on the table, and that is a reason to look at the living relatives rather than to close the file.

The coroner, the post-mortem, and why a cause is sometimes never found

A sudden, unexpected death is reported to the coroner in England and Wales, and a post-mortem is usually carried out. Where the heart is found to be structurally abnormal — a thickened muscle, a scarred or enlarged chamber — that finding often names the condition. Where the heart looks normal, the pathologist may retain a small tissue sample for what is sometimes called a molecular autopsy: genetic testing of the person who died, to look for an inherited fault that would not otherwise be visible.

This matters to the living family, because if a specific fault is identified in the person who died, relatives can be tested for that exact fault rather than screened in the dark. Even when nothing is found, the family screening offer usually still stands, because the absence of a result does not rule an inherited condition out. If you are also dealing with the practical aftermath — the paperwork, the accounts, the things nobody warned you about — our guides on the administrative side, including when HMRC says the person who died still owed tax for that year, cover ground that tends to arrive at the same time as the grief.

Who gets screened, and what the pathway looks like

The people usually offered screening are first-degree relatives: parents, siblings and children. They are the ones who share the most genetic material with the person who died, so they carry the highest chance of sharing an inherited fault. Wider relatives may be assessed later if something is found closer in.

Ask your GP for a referral to an inherited cardiac conditions service — sometimes called an ICC clinic or an inherited cardiovascular conditions service. This is the specialist NHS route, and it is set up for exactly this situation. A typical assessment begins with:

• an ECG, a simple recording of the heart's electrical activity;
• an echocardiogram, an ultrasound scan that shows the heart's structure and pumping;
• sometimes an exercise test, a longer heart-rhythm recording worn over a day or more, or a cardiac MRI where more detail is needed;
• and, where a fault has been identified in the person who died or is strongly suspected, a genetic test.

The British Heart Foundation has clear, calm explanations of these conditions and what the tests involve, written for families rather than clinicians, at the British Heart Foundation. None of it is a substitute for the clinic, but it can make the appointments less bewildering.

What the doctors are actually looking for

Two broad groups of inherited condition sit behind most sudden cardiac deaths in the young. The first is the cardiomyopathies, diseases of the heart muscle itself — for example a thickened muscle (hypertrophic cardiomyopathy), a stretched and weakened one (dilated cardiomyopathy), or one where muscle is replaced by fatty or fibrous tissue (arrhythmogenic cardiomyopathy). These usually show something on an echo or MRI.

The second group is the inherited arrhythmia syndromes, sometimes called channelopathies, which affect the heart's electrical system in a structurally normal heart — long QT syndrome, Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia among them. These are the ones that can leave a normal-looking heart at post-mortem, and they are often what an ECG-based screen is hunting for.

The reassuring thread through all of it is that these conditions can frequently be managed once they are known about — with medication, with lifestyle adjustments, and in some cases with an implanted device. What makes them dangerous is being undetected, not being untreatable. That is the whole logic of screening the family.

How a finding sits on a life insurance form

Here is where people get tangled, because the word "genetic" makes them assume everything from this pathway is protected. It is not, and the distinction is important enough to state plainly.

An ECG and an echocardiogram are not genetic tests. They are ordinary cardiac investigations. If one of them finds something — a rhythm abnormality, a thickened muscle, an enlarged chamber — that finding is ordinary medical evidence. If a life insurance application asks about investigations, tests, or heart conditions, a finding like that is disclosable and must be answered accurately. The same goes for any diagnosis, medication or device that follows.

A predictive genetic test is different. If, as part of the pathway, you have a predictive gene test — checking whether you carry an inherited fault while you are well — that result is protected under the Code on Genetic Testing and Insurance. Insurers cannot ask for it or use it for life cover. The single listed exception across all of insurance is Huntington's disease, and only for life cover above £500,000; the cardiac conditions are not on that list.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

So the line is clean. The scan and the ECG: disclosable if asked. The predictive gene result: protected. If you ever think an insurer has leaned on a protected result, there is a route to challenge it, which we set out in challenging a genetics decision and the deadlines involved. And because the pathway can begin with a relative's finding that cascades to you, the subtle question of what happens when cascade testing follows a research finding is worth understanding if that is how your own test came about.

If you are screened and found normal

This is the most common outcome, and it is worth saying clearly: being screened and found normal is a good thing on a form, not a bad one. Some people avoid the clinic because they fear that simply being tested will count against them with an insurer. It does not work that way. A normal ECG and a normal echo are reassuring pieces of evidence, and where you are asked about investigations you can report them honestly as clear.

What matters, as always, is answering the questions asked with reasonable care, rather than either hiding a finding or volunteering a protected gene result you were never asked for. Getting that balance right is the whole of it, and we explain why in our look at whether a claim can be refused over a family history question. If you were considering testing and cover at the same time, the ordering matters less here than American articles suggest — see whether to buy cover before genetic testing.

Putting the fear in proportion, and getting cover in place

A sudden death in a young sibling makes every future feel fragile, and that is entirely human. It helps to hold two things at once: take the screening offer seriously, because it can find something treatable, and also remember that the baseline odds for a healthy person of your age are steadier than grief makes them feel. Our piece on your real chance of dying before 65, in actual numbers is a more grounded reference point than a single terrible event, and the wider family history, inherited risk and the odds hub sets the whole subject out.

If part of what you are doing is making sure your own dependants are protected, that instinct is sound. Once you have been through screening and know where you stand medically, you can get life insurance quotes and have an FCA-authorised broker place the application in the right order — level term cover is the usual shape for family protection — so any cardiac findings are declared accurately while any predictive gene result stays where the Code keeps it.

Scotland and Northern Ireland

The medical pathway is broadly the same across the UK — first-degree relatives offered assessment through inherited cardiac conditions services — and the insurance rules are UK-wide, because both the Code on Genetic Testing and Insurance and the Consumer Insurance (Disclosure and Representations) Act 2012 apply throughout.

What differs is the investigation of the death itself. In Scotland there is no coroner; sudden and unexplained deaths are reported to and investigated by the Procurator Fiscal, who can instruct a post-mortem. In Northern Ireland the coroner system applies but operates under its own rules. In every nation, though, the important step for the living family is the same: ask for a referral to a specialist cardiac service, because that is where the screening that might protect you actually happens.

Frequently asked questions

What happens after an unexplained sudden cardiac death in the family?

The death is investigated — by the coroner in England, Wales and Northern Ireland, or the Procurator Fiscal in Scotland — and a post-mortem may identify a cause. Where none is found, first-degree relatives, meaning parents, brothers, sisters and children, are usually referred to an inherited cardiac conditions service for assessment, typically an ECG and an echocardiogram, sometimes with genetic testing alongside.

Should I be screened if my brother died suddenly?

Ask your GP for a referral to an inherited cardiac conditions clinic. UK practice is to screen first-degree relatives after a sudden unexplained death in someone young, because cardiomyopathies and inherited rhythm disorders can be present without any symptoms and are often treatable once they are found. The point of screening is to catch something manageable early, not to alarm you.

Does the screening affect life insurance?

An ECG or echocardiogram is not a genetic test, so any abnormality found is ordinary medical evidence and is disclosable if an insurer asks about investigations or heart conditions. A predictive gene test done as part of the same pathway is protected under the Code and cannot be asked for. Being screened and found normal is reassuring, not something to fear on a form.